Peetz Christopher bought MIRM
November 18, 2025 · Form 4 insider transaction
Peetz Christopher bought 19,133 shares of Mirum Pharmaceuticals, Inc. at $19.24 per share, a transaction worth $368.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
19,133
Price
$19.24
Total value
$368.1K
InsiderPeetz Christopher
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 18, 2025
Filing dateNovember 20, 2025
Shares owned after158,034
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 260 shares of Common Stock that were acquired by the Reporting Person on November 10, 2025, pursuant to the Issuer's Employee Stock Purchase Plan.